Suppr超能文献

婴儿猝死与肝脏磷酸烯醇式丙酮酸羧激酶分析

Sudden infant death and liver phosphoenolpyruvate carboxykinase analysis.

作者信息

Sturner W Q, Susa J B

出版信息

Forensic Sci Int. 1980 Jul-Aug;16(1):19-28. doi: 10.1016/0379-0738(80)90175-9.

Abstract

In an effort to substantiate the impaired gluconeogenesis-terminal hypoglycemia hypothesis of sudden infant death syndrome (SIDS), 52 infants ranging from 3 weeks to 7 months of age which had been brought to autopsy were studied. The stomach contents, vitreous humor glucose concentrations, hepatic glycogen content and hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity were measured as part of the laboratory component of the postmortem investigation. The stomach contents, vitreous humor glucose concentrations and liver glycogen content were similar in SIDS/and non-SIDS victims. PEPCK activity was, however, significantly lower in SIDS (p < 0.001) victims and in SIDS with other findings (p < 0.01) victims when compared to non-SIDS victims. Despite the fact that SIDS victims had lower hepatic PEPCK activity and hence potentially lower gluconeogenic capacity, terminal hypoglycemia could not be demonstrated in this group as compared to the SIDS with other findings and the non-SIDS infants. The impaired gluconeogenesis-terminal hypoglycemia hypothesis thus could not be substantiated.

摘要

为了证实婴儿猝死综合征(SIDS)的糖异生受损-终末期低血糖假说,对52例年龄在3周龄至7月龄、已进行尸检的婴儿进行了研究。作为尸检调查实验室部分的内容,测定了胃内容物、玻璃体液葡萄糖浓度、肝糖原含量和肝磷酸烯醇式丙酮酸羧激酶(PEPCK)活性。SIDS患儿与非SIDS患儿的胃内容物、玻璃体液葡萄糖浓度和肝糖原含量相似。然而,与非SIDS患儿相比,SIDS患儿(p<0.001)以及伴有其他发现的SIDS患儿(p<0.01)的PEPCK活性显著降低。尽管SIDS患儿的肝PEPCK活性较低,因此糖异生能力可能较低,但与伴有其他发现的SIDS患儿和非SIDS婴儿相比,该组患儿未发现终末期低血糖。因此,糖异生受损-终末期低血糖假说未能得到证实。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验